detail in Medical News

New Jersey Leaders Detail Savings for Health Reform

Former Governor Jim Florio and NJ Quality Institute President David Knowlton Are Joined by Key Business Leaders TRENTON, N.J., July 1 /PRNewswire/ -- Saying that the savings from chronic disease prevention and treatment "can fill the funding gap for health care reform," the New Jersey Partner...

Economists to Declare Health Reform Key to Recovery; New Reports Detail Employer Health Mandate

Two New Reports To Be Released Tuesday Show Employer Health Mandate Would Help Save Jobs, Details How To Structure A "Play-or-Pay" System WASHINGTON, June 15 /PRNewswire-USNewswire/ -- Hundreds of economists will declare that a bad economy should not delay overhauling the nation's health care...

Plain-Language Guides Detail Insulin Treatments

U.S. agency compiles comparison of therapies for both doctors and patients THURSDAY, April 2 (HealthDay News) -- New "plain language" guides from the federal government spell out the differences between available treatments for type 2 diabetes for patients and doctors alike. The gu...

Aflac Incorporated Provides Added Detail on Perpetual Debenture Holdings

COLUMBUS, Ga., Feb. 6 /PRNewswire-FirstCall/ -- Aflac Incorporated announced today that it is providing expanded detail on its holdings of perpetual debenture securities at aflac.com. The company has elevated additional information to its web site on each Upper Tier 2 and Tier 1 perpetu...

AHCA/Alliance Detail Components of Long Term Care Economic Recovery, Jobs Plan

Proposal Focuses on State Medicaid Payment Accountability, LTC Sector Access to Capital, HIT, Workforce WASHINGTON, Jan. 22 /PRNewswire-USNewswire/ -- Emphasizing both the need and opportunity to collaborate with President Obama and Congress to continue improving nursing home care quality, cr...

Researchers detail how aging undermines bone healing

Researchers have unraveled crucial details of how aging causes broken bones to heal slowly, or not at all, according to study results published today in the Journal of Bone and Mineral Research . The research team also successfully conducted preclinical tests on a potential new class of treatment...

Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures

LOS GATOS, Calif., Dec. 16 /PRNewswire/ -- TriCipher will host an informative Webinar detailing the cost cutting capabilities of digital signatures for the pharmaceutical and health care industries and strategies for securing digital signatures as more business processes transition online. The o...

Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the HiArt treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Symposium speakers highlighted the HiArt syste...

Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives

The Detail Bag II is an integrated sales tool designed for pharmaceutical representatives and other sales professionals who carry samples. The new Detail Bag II (DB2) is 25 percent smaller than the first Detail Bag (DB-XL). This thin, lighter "road ready" sample case was inspired by ...

Vivisimo Case Studies Detail Innovative Enterprise Search Applications by Medical Libraries, Women's Health Site

PITTSBURGH, July 8 /PRNewswire/ -- Facing a blizzard of health-related information, consumers and medical practitioners can benefit from authoritative sources to help sort good from bad and keep up-to-date on new discoveries and procedures. Vivisimo (vivisimo.com), a market leader in enterpris...

Study in Circulation provides detail on how low blood flow promotes vascular disease

Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation . The work establishes cyclophilin A as an exciting targe...

Report to Detail How Manor Care Buyout by The Carlyle Group Could Hamper Care for Florida Nursing Home Residents

New research to detail how $400 million in new interest expense from Carlyle deal could harm Florida nursing home residents MIAMI, Nov. 6 /PRNewswire/ -- WHAT: On the day that the Manor Care nursing home chain tells the SEC that it expects to close its $6.6 billion buyout ...

Patient Photos Spur Radiologist Empathy and Eye for Detail

CHICAGO, Dec. 2 /PRNewswire-USNewswire/ -- Including a patient's photo with imaging exam results may enable a more meticulous reading from the radiologist interpreting the images, as well as a more personal and empathetic approach, according to a study presented today at the annual meeti...

Patient photos spur radiologist empathy and eye for detail

CHICAGO Including a patient's photo with imaging exam results may enable a more meticulous reading from the radiologist interpreting the images, as well as a more personal and empathetic approach, according to a study presented today at the annual meeting of the Radiological Society of North Amer...

Autoimmune disorders studied in detail by U-M researchers.

University of Michigan researchers have been able to zero in (on) the modalities of a drug, capable of rectifying autoimmune disorders and other types of diseases. // Clinical trials on animal models have revealed the capacity of the drug to reduce the potency of a key enzyme, in charge of energy p...

A Detail Analysis of Head and Neck Cancer

The discovery of the molecular mechanism behind the aggressive head and neck cancer was unveiled by the researchers at the San Francisco VA Medical Center (SFVAMC). // It is a highly malignant form of cancer with a very high death rate. They have discovered the triple interaction between CD44, hya...

Fat metabolism in fish to be studied in detail

Canterbury University researcher Dr Victoria Metcalf is out to delve into the Antarctic seas for some answers about fish. Metcalf will use the genetic filter technology// to understand how fish actually metabolize fat. This study will aid in the understanding of the existing connection between fat ...

Omega Protein Reports 2009 Second Quarter Results

...worldwide prices for competing products; and (5) the impact of the capital and credit market crisis. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its reports on Form 10-K, Form10-Q and Form 8-K. The Company also posts its...

MedCath Corporation Reports Third Quarter Earnings

...easonable possibility that actual results may vary significantly from those estimates. These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Annual Report or Form 10-K for the year ended September 30, 2008 filed with the Securities and Exchange Commission on D...

Recondo Technology Introduces New Software Service for Hospitals

...ing issues by delivering the most comprehensive insurance eligibility benefits and data available. EligibilityPlus achieves this unprecedented benefit detail by combining standard eligibility Electronic Data Interchange (EDI) transactions with benefits available only on payer web-portals. "Eligibilit...

FDA extends review of Pennsaid(R) diclofenac sodium topical solution

... material weakness in accounting for income taxes or potential environmental liabilities. These and other factors are identified and described in more detail in our filings with the SEC. We disclaim any obligation to update these forward-looking statements other than as required by law. ...

Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer

...m those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov . Bionovo, Inc. is under no obligation (and...

Cardiome Announces Management Transition

...ted to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Securities and Exchange Commission available at www.sec.gov and the Canadian securities regulatory authorities at www.sedar...

Uroplasty Reports First Fiscal Quarter Results

...ing statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC. Further, we cannot...

Warner Chilcott Announces Receipt of Paragraph IV Certification Notices

...ompany during the second half of 2006, is protected by U.S. Patent No. 6,667,050 which expires in 2019. The Company is currently reviewing the detail of the Paragraph IV Certification Notices from Lupin and continues to have full confidence in its intellectual property protecting LOESTRIN 24 FE and ...

WebMD Announces Second Quarter Financial Results

...rivate portal services revenue. Income from continuing operations is estimated to be 10% of revenue for the third quarter of 2009. Additional detail is provided in a schedule attached to this release. Analyst and Investor Conference Call As previously announced, WebMD will hold a confe...

Endologix Announces Pricing of Public Offering of Common Stock

...ements. Factors that could cause actual results to differ materially from those indicated by such forward-looking statements are described in greater detail under the heading "Risk Factors" contained in the Company's periodic SEC filings. Given these uncertainties, you should not place undue reliance on t...

Express Scripts Reports Strong Second Quarter Earnings

...NextRx transaction). See Table 3. (3) The Company incurred other non-recurring charges related to the transaction which are described in more detail in Table 3. The Company estimates further costs to be incurred in Q3 / Q4 2009 of $70 million - $80 million primarily for professional fees (b...

Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference

...boration of partners, the CDC is using the conference to help build a "National Road Map for Obesity Prevention and Control"; a set of guidelines that detail investment in integrated obesity prevention and control initiatives. "Clinical prevention is critical for a healthcare organization. Because ...

Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance

...he preferred stock was converted to common stock at the beginning of the period. The preferred stock dividend and conversion are explained in greater detail later in this press release. Earnings per share for the quarter ended June 30, 2008 on a GAAP basis was $0.11 per diluted share. The $12.3 mi...

New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians

...ask Force criteria. Following a formal process, they also developed multiple systematic reviews along with multiple associated documents describing in detail the process in the literature search and systematic reviews. Dr. Manchikanti added that, "These guidelines follow the principles laid out by t...

SCAI Opposes U.S. House of Representatives Health Reform Bill in Current Form

...ed that major advances in cardiovascular care will be hindered by the current approach to reform. SCAI's letter to Congress provides additional detail on the Society's position and is available at http://www.scai.org/pdf/2009July23HealthCareReform.pdf About SCAI The mission of the S...

Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.

...ted to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Securities and Exchange Commission available at www.sec.gov and the Canadian securities regulatory authorities at www.sedar...

When You Make Things That Get Implanted in People, Small Things Count

...y software. This allows SSF engineers to fine-tune their measurement systems and ensure repeatable results with confidence. It's attention to detail and the small things that add up to big results when manufacturing implantable silicone products. All of this points to the incredible skill and dedic...

QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System

...erty rights and the impact of patents and other intellectual property of third parties; and general economic conditions and other factors described in detail in QLT's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission and Canadian se...

QLT Announces Second Quarter Results for 2009

...erty rights and the impact of patents and other intellectual property of third parties; and general economic conditions and other factors described in detail in QLT's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission and Canadian se...

Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement

...n of these risks, uncertainties, and other factors are described in greater detail in Raptor's filings from time to time with the Securities and Exchange Comm... and other risks which may cause results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K fo...

Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009

... from those expressed or implied by such forward-looking statements . These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, and the Company's other Periodic and Current Reports filed with the ...

Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29

...curities under SFAS No. 123R. Amgen Inc. Product Sales detail by Product and Geographic Region (In millions) (Unaudited) ...nding 1,015 1,047 (a) As discussed in more detail above in the notes to the Reconciliation of GAAP Earnings to "Adjus...

Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact

...eveal. The product supports multi-dimensional financial information for organizations with data sets containing upwards of tens of billions of rows of detail transactions. HOPS Reveal is provided in a Software As a Service (SaaS) model and must scale to support millions of licensed users. ...